Traditional Chinese medicine decoction for treating hyperplasia of mammary glands

Abstract

The invention relates to the field of medicine formulas and particularly relates to traditional Chinese medicine decoction for treating hyperplasia of mammary glands. The traditional Chinese medicine decoction is characterized by being prepared from the following crude drugs in percentage by weight: 4-8% of deer face plates, 5-8% of viola inconspicua, 5-8% of rhizoma cyperi, 3-6% of selfheal, 5-8% of herb of glabrous sarcandra, 4-7% of adiantum, 6-9% of rhizoma typhonii, 6-9% of fructus meliae toosendan, 4-6% of tea tree root, 5-7% of fructus Liquidambaris, 5-7% of spina gleditsiae, 3-5% of geranium nepalense, 3-5% of elecampane, 2-5% of dillseed, 3-6% of oldenlandia diffusa, 2-5% of notopterygium root, 3-5% of albizia flowers and 5-8% of rhizoma sparganii. The 18 crude drugs are soaked in water and decocted, and then the residue is removed to obtain filtrate. The traditional Chinese medicine decoction has effects of soothing the liver to regulate qi, invigorating the circulation of blood, activating meridians to stop pain and reducing phlegm and resolving masses, has effects of treating both manifestation and root cause of disease for the hyperplasia of mammary glands, and is small in side effect.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a Chinese medicine decoction for treating mammary gland hyperplasia. Background technique [0002] As we all know, mammary gland hyperplasia is the most common breast disease in women, and its incidence rate accounts for the first place in breast diseases. In recent years, the incidence of the disease has been increasing year by year, and the age is getting younger and younger. Mammary gland hyperplasia refers to the hyperplasia of breast epithelial and fibrous tissue, often manifested as breast tenderness and breast lumps, pain is usually unilateral or bilateral breast tenderness or tenderness, periodic pain, occurs or aggravates during premenstrual period. It mostly occurs in women aged 30-50, and the peak incidence is 35-40 years old. [0003] At present, the treatment of mammary gland hyperplasia is mainly based on surgical therapy, which is generally not easily acce...

AI Technical Summary

Problems solved by technology

[0003] At present, the treatment of mammary gland hyperplasia is mainly surgical therapy, which is generally not easily accepted by patients

There are also many kinds of drugs for the treatment of mammary gland hyperplasia. Commonly used western medicines include the antihormonal drug tamoxifen, the androgen drug prosterone or methyl testosterone, and prolactin drugs. Although these drugs have certain curative effects, they take a long time and are prone to relapse , can easily cause iatrogenic injury, and the side effects are relatively large, so it is not suitable for long-term use

Images